You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK)全年多賺29%增派息 惟AH股續吐近6%-7%
阿思達克 03-23 11:37
復星醫藥(02196.HK)全年多賺29%末期息年增30%,但該股繼昨天回吐結束四連升後,今天平開報後股價反覆續吐,高低見38.7元/35.05元,現報35.45元,續吐6.7%,成交1,369萬股;復星醫藥(600196.SH)由高位連跌第二天,最低見50.91元人民幣,半日收51.09元人民幣,續吐5.8%。 復星醫藥公佈,去年純利按年升29.3%至47.35億元人民幣(下同),每股盈利1.85元,末期股息按年增30%至56分。期內,總營收按年升近29%至388.58億元;其中製藥業務實現營收按年升32.3%至287.72億元。 集團去年計提長期股權投資減值準備4.6億元、計提商譽減值準備1.5億元,合共計提資產減值準備6.12億元。今次計提資產減值準備導致集團去年純利減少6.12億元、歸屬於母公司淨利潤減少5.7億元、2021年底歸屬於上市公司股東所有者權益減少5.7億元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account